Top Markets
#1 Official Trump Official Trump +44.68%
#2 Melania Meme Melania Meme +22.66%
#3 EXOD EXOD +22.08%
#4 Movement Movement +19.54%
#5 Mubarak Mubarak +18.92%
#6 Wrapped POL Wrapped POL +18.17%
#7 POL (ex-MATIC) POL (ex-MATIC) +17.83%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +17.59%
#9 Unit Pump Unit Pump +11.33%
#10 Pump.fun Pump.fun +11.33%
Coin of the day
Official Trump Official Trump
設定
言語
日本
通貨
USD
テーマ
Aeglea BioTherapeutics, Inc. Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

AGLE
株式のランク #23495
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated... Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating human enzyme therapies for rare metabolic diseases. Their leading candidate, pegzilarginase, a recombinant human Arginase 1, is currently in the pivotal Phase III PEACE trial to assess its safety and effectiveness for treating Arginase 1 deficiency. Furthermore, the company is developing AGLE-177, a polyethylene glycol modified enzyme, which is progressing through Phase I/II clinical trials for homocystinuria. Their early-stage pipeline includes AGLE-325 for cystinuria, along with other ongoing research initiatives. Founded in 2013, the company was initially known as Aeglea BioTherapeutics Holdings, LLC, changing its name to Aeglea BioTherapeutics, Inc. in March 2015. It is based in Austin, Texas.
株価
$19.30
最終同期: 2023-12-26
時価総額
$72.77M
変化（1日）
6.22%
変化（1年）
0.00%
国
US
取引 Aeglea BioTherapeutics, Inc. (AGLE)

カテゴリー

Healthcare
Aeglea BioTherapeutics, Inc.（AGLE）の収益
Aug 2026 時点の収益 TTM: 0
Aeglea BioTherapeutics, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Aeglea BioTherapeutics, Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH